Nuzenio

Dmd Therapy

Dmd Therapy news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 20 latest news signals 17 publisher sources 100/100 entity strength

Latest news

Capricor’s DMD Therapy Gets Lancet Backing Ahead Of August FDA Showdown – CEO Says Publication ‘Reinforce Our Confidence’ For Approval - StocktwitsStocktwits · Fri, 07 Aug 2026 01:26:29 GMTExpanded access program to bring DMD treatment to patients in 1 US state - musculardystrophynews.commusculardystrophynews.com · Thu, 06 Aug 2026 19:04:33 GMTSarepta’s new CEO Michael Severino faces critical milestones to prove growth - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 15:15:32 GMTIQVIA Partners With Medera on Cardiac Gene Therapy Development - The Clinical Trial VanguardThe Clinical Trial Vanguard · Wed, 05 Aug 2026 07:37:44 GMTCapricor seeks court intervention in fight over DMD cell therapy launch - FirstWord PHARMAFirstWord PHARMA · Wed, 05 Aug 2026 07:00:00 GMTCapricor’s Duchenne AdCom Didn’t Fail on Science. It Failed on Statistics. - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 04 Aug 2026 07:38:27 GMTUAB and Children’s expand access to promising therapy for Duchenne muscular dystrophy - The University of Alabama at BirminghamThe University of Alabama at Birmingham · Mon, 03 Aug 2026 17:25:55 GMTFDA AdCom shuns Capricor’s DMD cell therapy amid data dispute - Pharmaceutical TechnologyPharmaceutical Technology · Thu, 30 Jul 2026 14:06:52 GMT

Timeline

Fri, 07 Aug 2026 01:26:29 GMTCapricor’s DMD Therapy Gets Lancet Backing Ahead Of August FDA Showdown – CEO Says Publication ‘Reinforce Our Confidence’ For Approval - Stocktwits
Thu, 06 Aug 2026 19:04:33 GMTExpanded access program to bring DMD treatment to patients in 1 US state - musculardystrophynews.com
Thu, 06 Aug 2026 15:15:32 GMTSarepta’s new CEO Michael Severino faces critical milestones to prove growth - Fierce Pharma
Wed, 05 Aug 2026 07:37:44 GMTIQVIA Partners With Medera on Cardiac Gene Therapy Development - The Clinical Trial Vanguard
Wed, 05 Aug 2026 07:00:00 GMTCapricor seeks court intervention in fight over DMD cell therapy launch - FirstWord PHARMA
Tue, 04 Aug 2026 07:38:27 GMTCapricor’s Duchenne AdCom Didn’t Fail on Science. It Failed on Statistics. - The Clinical Trial Vanguard

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Dmd Therapy.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

17 distinct publisher/source names are currently connected to this entity page.